References
- Mobacken H, Holst R, Wengström C, Holm SE. Epidemiological aspects of impetigo contagiosa in western Sweden. Scand J Infect Dis 1975; 7: 39–44.
- Elmrud H. Impetigo – fusidinresistent Staphylococcus aureusstam dominerar fortfarande. Report from the county medical officer in Skåne. Sweden (Smittskydd Skåne) 2002; 1: 10–1.
- Koning S, van Suijlekom-Smit LWA, Nouwen JL, Verduin CM, Bernsen RMD, Oranje AP, et al. Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial. Br Med J 2002; 324: 1–5.
- Morley PA, Munot LD. A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis. Curr Med Res Opin 1988; 11: 142–8.
- Christensen OB, Anehus S. Hydrogen peroxide cream: an alternative to topical antibiotics in the treatment of impetigo contagiosa. Acta Derm Venereol 1994; 74: 460–2.
- Runehagen A. Okänd smitta blev bullös impetigo. Report from the county medical officer in Kronoberg. Sweden (Smittkällan) 1999; 6: 1.
- Edén T. Svinkoppor & fusidinresistenta stafylokocker – ut- bredd klonal spridning. Report from the county medical officer in Skåne. Sweden (Smittskydd Skåne) 2000; 2: 4–5.
- Swedish Reference Group of Antibiotics (SRGA). Antimicrobial susceptibility testing in Sweden. Scand J Infect Dis Suppl 1997; 105: 8–31. See also subsequent updates available at http://www.srga.org
- Kahlmeter G, Olsson-Liljequist B, Ringertz S. Antimicrobial susceptibility testing in Sweden – quality assurance. Scand J Infect Dis Suppl 1997; 105: 24–31.
- Maslow JN, Slutsky AM, Arbeit RD. Application of pulsedfield gel electrophoresis to molecular epidemiology. In: Persing DH, Smith TF, Tenover FC, White TJ, eds. Diagnostic molecular microbiology: principles and applications. Washington, D.C.: American Society for Microbiology, 1993: 563–72.
- Statistics Sweden. http://www.scb.se
- Turnidge J, Collignon P. Resistance to fusidic acid. Int J Antimicrob Agents 1999; 12 (Suppl 2): S35–44.
- Tveten Y, Grude N, Kristiansen B-E. Impetigo bullosa og stafylokocker. Norwegian surveillance system for communicable diseases (MSIS) 2001; 40: 1.
- Brown EM, Thomas P. Fusidic acid resistance in Staphylococcus aureus isolates. Lancet 2002; 359: 803.
- Bronzwaer SLAM, Cars O, Buchholz U, Mölstad S, Goettsch W, Veldhuijzen IK, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002; 8: 278–82.
- García-Rey C, Aguilar L, Baquero F, Casal J, Dal-Ré R. Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. J Clin Microbiol 2002; 40: 159–64.
- Melander E, Ekdahl K, Jonsson G, Mölstad S. Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr Infect Dis J 2000; 19: 1172–7.
- Seppälä H, Klaukka T, Vuopio-Varkila J, Moitiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997; 337: 441–6.
- Ravenscroft JC, Layton A, Barnham M. Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK. Clin Exp Dermatol 2000; 25: 327–30.